Post-Treatment Lyme Disease Syndrome: Why Symptoms Persist
Persistent symptoms may continue after Lyme disease treatment.
Fatigue, pain, and cognitive dysfunction can significantly affect quality of life.
The cause of ongoing illness remains actively debated.
Some patients continue experiencing fatigue, pain, cognitive dysfunction, and neurologic symptoms after standard Lyme disease treatment.
This condition is commonly referred to as post-treatment Lyme disease syndrome (PTLDS), though some patients and clinicians also use the term chronic Lyme disease.
Studies estimate that between 34% and 62% of patients may continue reporting persistent symptoms after treatment.
In one population-based retrospective cohort, approximately 34% of patients remained ill an average of 6.2 years after antibiotic therapy.
These ongoing symptoms can substantially affect daily functioning and quality of life.
Persistent Symptoms Can Be Severe
Several National Institutes of Health (NIH)-sponsored clinical trials highlighted the potential severity of persistent Lyme disease symptoms.
According to these studies, quality-of-life impairment in chronically ill Lyme disease patients was comparable to that seen in conditions such as congestive heart failure and multiple sclerosis.
Patients may experience:
- Severe fatigue
- Brain fog
- Sleep disturbances
- Joint and muscle pain
- Headaches
- Neurocognitive dysfunction
- Autonomic symptoms
Up to 90% of patients with post-treatment Lyme disease syndrome (PTLDS) report cognitive symptoms such as brain fog, memory issues, and slowed processing. Advanced imaging (PET, fMRI, DTI) in these patients shows evidence of inflammation, glial activation, and changes in white matter structure.[2]
Learn more about overlapping neurologic symptoms in Neuropsychiatric Lyme Disease.
Why Do Symptoms Persist?
The cause of persistent symptoms after Lyme disease treatment remains controversial and actively debated.
In an editorial published in the Journal of Clinical Investigation, Dr. Allen Steere proposed that several distinct post-treatment syndromes may explain ongoing symptoms in different patient groups.
Steere acknowledged that patients may remain seriously ill, describing severe pain, fatigue, headache, brain fog, and sleep dysfunction that significantly impair quality of life.
However, Steere argued that maladaptive immune or postinfectious responses may explain many cases rather than ongoing active infection.
Some clinicians disagree with this interpretation and continue supporting the possibility that persistent infection may contribute to ongoing illness in selected patients.
This debate remains central to discussions surrounding PTLDS and chronic Lyme disease.
Four Proposed Post-Treatment Lyme Disease Syndromes
Steere proposed several possible post-treatment syndromes following Lyme disease:
Post-Infectious Lyme Arthritis
This syndrome involves persistent inflammatory arthritis, often affecting the knee, following Lyme arthritis.
Proposed mechanisms include excessive pro-inflammatory immune responses and impaired wound repair processes.
Post-Treatment Lyme Disease Syndrome
This syndrome includes fatigue, pain, and neurocognitive symptoms emerging after Lyme disease.
One proposed mechanism involves abnormal sensory processing or central sensitization following infection.
Learn more about central sensitization syndrome and Lyme disease.
Autoimmune Joint Disease
Some individuals may develop autoimmune joint conditions such as rheumatoid arthritis or psoriatic arthritis after Lyme disease.
Steere proposed that infection may activate latent autoimmune pathways in susceptible individuals.
Autoimmune Neurologic Disease
Steere also discussed possible autoimmune neurologic complications following Lyme radiculoneuropathy.
The exact mechanisms remain uncertain.
Persistent Infection Debate Continues
The question of whether persistent infection contributes to ongoing Lyme disease symptoms remains controversial.
Some clinicians argue that persistent symptoms primarily reflect immune dysregulation or postinfectious mechanisms.
Others believe that persistent infection may continue contributing to illness in at least a subset of patients.
As an author of the International Lyme and Associated Diseases Society (ILADS) guidelines, I do not dismiss the persistent infection hypothesis and support individualized treatment decisions based on clinical response and ongoing symptoms.
Learn more about ongoing discussion surrounding Persistent Lyme Disease.
Frequently Asked Questions
What is post-treatment Lyme disease syndrome?
Post-treatment Lyme disease syndrome (PTLDS) describes persistent symptoms such as fatigue, pain, and cognitive dysfunction after Lyme disease treatment.
How long can PTLDS symptoms last?
Some patients remain symptomatic for months or years following treatment.
Can Lyme disease cause long-term cognitive symptoms?
Yes. Brain fog, slowed processing, memory problems, and concentration difficulties are commonly reported in PTLDS.
Is PTLDS the same as chronic Lyme disease?
The terms are sometimes used differently. PTLDS is the formal research term, while chronic Lyme disease is used more broadly by some clinicians and patients.
Do experts agree on the cause of PTLDS?
No. Persistent infection, immune dysfunction, inflammation, autonomic dysfunction, and central sensitization remain areas of ongoing debate and research.
Clinical Takeaway
Post-treatment Lyme disease syndrome remains one of the most debated areas in Lyme disease medicine.
Persistent fatigue, pain, neurocognitive dysfunction, and neurologic symptoms can significantly impair quality of life, and the underlying mechanisms likely vary between patients.
Related Articles
Learn more about broader neurologic complications in Neurologic Lyme Disease.
Explore diagnostic complexity in Lyme Disease Misdiagnosis.
Review broader symptom patterns in the Lyme Disease Symptoms Guide.
Learn more about recovery challenges in Recovery From Lyme Disease.
Explore autonomic overlap in Autonomic Dysfunction in Lyme Disease.
References
- Steere AC. Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses. J Clin Invest. 2020;130(5):2148-2151.
- Fallon BA, Keilp JG, Prohovnik I, Heertum RV, Mann JJ. Regional cerebral blood flow and cognitive deficits in chronic Lyme disease. J Neuropsychiatry Clin Neurosci. 2008;20(3):326-332.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
Question about the use of “post-treatment” language. Do these syndromes apply only to those who were treated while in acute phase? Or to anyone post-acute? For example, in my case, my bite was confirmed many years after the fact, and I had never had treatment, but certainly have post-acute-stage issues. In other words, are the syndromes above truly related to the typical treatments applied during acute stage, or to the Lyme infection itself?
I am not a fan of the term “post-treatment” as some doctors assumed there is no evidence of persistent infection. Some have used the term if symptoms persist after 3 weeks of antibiotics.
Ok, are you saying that these 4 syndromes are really post-infection, and not related to the treatment itself? But using the “post-treatment” label out of convenience. What I’m trying to understand is whether these syndromes result from the treatment or result from the infection.
They four syndromes are from the infection. The doctor assumes the infection has cleared.
I have had lyme doxi treatment numerous times over last few years. I now have a painful 2.5 cm lump in a groin lymph node. The lyme test shows prior lyme infections. Have you seen lymphoma from lyme after treatment? My primary thinks I push a lyme diagnosis too much as the root cause of fibromyalgia and brain fog.
I have not seen Lymphoma after treatment for Lyme disease. You need to see a doctor, i.e. surgeon or oncologist for an evaluation. I have patients with both Lyme disease and cancer. I have had to treat their Lyme disease along with their oncologist. Call my office at 914 666 4665 if you have any questions.
Does your pcp have any other ideas .. what’s wrong with treating your symptoms … just don’t bundle everything into one diagnosis because those words, chronic Lyme can bring a shit storm down on the the pcp’s head … I have the same issues as you do plus post sepsis syndrome which gets the same treatment .. they seem more open to post Covid symptoms which appear to be similar to both post Lyme and post sepsis .. they all three share massive inflammation as a common thread .. perhaps the post Covid issues will drive research that could help us all
Dr Cameron, in addition to (or apart from) borrelia/lyme infections, have you found other bacteria to be “persistent” such as Tularemia, Bartonella, Brucella and Babesia? Thank you sir,
I am not sure any one has looked at other infections.
The doc I’m seeing to treat Lyme put me on clarithromycin and cefuroxime twice a day . No length of treatment but provided 30 day supply with 1 refill. Unable to call MD to ask if I take it 30 or 60 days. Any thoughts? His office reopens 1/4/2021
1/4/21 is nearly here. I would typically extend therapy few a days until I could make an appointment for a reassessment. I cannot comment on your treatment.
Using a 2014 study to support his theory with 36 patients and one-third of them being his control group? Most others references were all based on his lunacy. I get so angry thinking anyone pays attention to the likes of this “Physician”. I was diagnosed 20 years ago in Ct. Although I was treated well by some of the best ILADS Doctors- I am living proof That Chronic LD exists. Ten years of remission and poof- gone in a minute! There was little or no testing for co-infections back then although I was treated for two of them for a while. Treatment options are near impossible having moved to a Southern State that denies LD exists here. Thank you for all your work Dr. Cameron. he best I can offer is to educate others so they learn and seek treatment soon!